Baltimore, MD, United States of America

Chih-Ping Mao

USPTO Granted Patents = 3 

Average Co-Inventor Count = 4.1

ph-index = 1


Company Filing History:


Years Active: 2024-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations in Cancer Treatment by Chih-Ping Mao

Introduction

Chih-Ping Mao is a notable inventor based in Baltimore, MD (US). He has made significant contributions to the field of cancer treatment through his innovative patents. With a total of 3 patents, Mao's work focuses on methods and materials that enhance the detection and treatment of cancer in mammals.

Latest Patents

One of his latest patents is titled "Methods and materials for treating cancer." This document relates to methods and materials for assessing and/or treating mammals, such as humans, who have or are suspected of having cancer. It includes innovative microfluidic devices designed to detect cancer-specific polypeptides in fluid samples obtained from mammals. Another significant patent is "Non-invasive cancer detection and analysis by single-molecule imaging." This patent describes chips for detecting targets in a sample, featuring a microfluidic flow chamber with flow channels and a capture surface. The methods outlined in this patent utilize total internal reflection fluorescence (TIRF) for target identification.

Career Highlights

Chih-Ping Mao is affiliated with The Johns Hopkins University, where he continues to advance research in cancer detection and treatment. His work is characterized by a commitment to developing non-invasive techniques that can significantly improve patient outcomes.

Collaborations

Mao collaborates with esteemed colleagues, including Chien-Fu Hung and Shih-Chin Wang, who contribute to his research endeavors and innovations in the field.

Conclusion

Chih-Ping Mao's contributions to cancer treatment through his innovative patents reflect his dedication to improving healthcare. His work not only enhances detection methods but also paves the way for more effective treatments for cancer patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…